Published in J Med Microbiol on July 01, 2004
Age-related gene expression in Tourette syndrome. J Psychiatr Res (2008) 0.89
Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol (2016) 0.88
Traditional management of ear, nose and throat (ENT) diseases in Central Kenya. J Ethnobiol Ethnomed (2006) 0.87
Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology. Eur Arch Otorhinolaryngol (2011) 0.86
Mycoplasma pneumoniae respiratory tract infections among Greek children. Hippokratia (2011) 0.83
Helicobacter pylori infection in the pharynx of patients with chronic pharyngitis detected with TDI-FP and modified Giemsa stain. World J Gastroenterol (2006) 0.79
Role of atypical bacteria in children undergoing tonsillectomy because of severely recurrent acute tonsillopharyngitis. Eur J Clin Microbiol Infect Dis (2008) 0.78
Beta-lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis Pharyngitis patients. J Clin Microbiol (2007) 0.76
The possible association of Chlamydia pneumoniae infection with nasal polyps. Eur Arch Otorhinolaryngol (2006) 0.75
The effect of telithromycin in acute exacerbations of asthma. N Engl J Med (2006) 5.35
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis (2012) 4.62
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia. Eur Respir J (2013) 2.69
Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. Chest (2015) 2.66
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest (2009) 2.34
Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med (2006) 2.28
The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev (2003) 2.22
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J (2013) 2.20
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest (2013) 2.19
A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 2.08
Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine (2005) 2.04
The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis (2011) 1.97
Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax (2013) 1.92
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood (2004) 1.83
uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol (2004) 1.71
Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med (2014) 1.53
Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J (2003) 1.52
Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother (2012) 1.51
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis (2008) 1.49
Bronchiectasis: an update. Clin Respir J (2009) 1.48
Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med (2013) 1.48
Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol (2005) 1.48
Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med (2013) 1.47
Collection by trained pediatricians or parents of mid-turbinate nasal flocked swabs for the detection of influenza viruses in childhood. Virol J (2010) 1.47
Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections. Pediatr Infect Dis J (2005) 1.47
Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol (2006) 1.46
Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index. Eur Respir J (2013) 1.45
Clinical assessment of adenoidal obstruction based on the nasal obstruction index is no longer useful in children. Otolaryngol Head Neck Surg (2010) 1.42
Tuberculosis elimination: theory and practice in Europe. Eur Respir J (2014) 1.42
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax (2013) 1.41
ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes. Crit Care Med (2013) 1.41
Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect (2011) 1.40
Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem (2005) 1.33
Impact of human coronavirus infections in otherwise healthy children who attended an emergency department. J Med Virol (2006) 1.31
Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol (2007) 1.30
Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med (2014) 1.29
Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses. Influenza Other Respir Viruses (2012) 1.29
Management of fever in children: summary of the Italian Pediatric Society guidelines. Clin Ther (2009) 1.28
A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny. Development (2005) 1.25
Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine (2003) 1.25
Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J Biol Chem (2002) 1.25
Comparison of nasopharyngeal nylon flocked swabs with universal transport medium and rayon-bud swabs with a sponge reservoir of viral transport medium in the diagnosis of paediatric influenza. J Med Microbiol (2010) 1.22
Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. Cell Rep (2013) 1.21
The urokinase receptor as an entertainer of signal transduction. Front Biosci (Landmark Ed) (2009) 1.21
Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. J Clin Invest (2009) 1.19
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J Biol Chem (2003) 1.19
Expression of Hoxa2 in rhombomere 4 is regulated by a conserved cross-regulatory mechanism dependent upon Hoxb1. Dev Biol (2006) 1.17
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol (2005) 1.17
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest (2004) 1.17
MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood (2004) 1.15
An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol Biol Cell (2005) 1.15
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci (2004) 1.14
Hoxb1 enhancer and control of rhombomere 4 expression: complex interplay between PREP1-PBX1-HOXB1 binding sites. Mol Cell Biol (2005) 1.14
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers. Clin Vaccine Immunol (2010) 1.12
Prep1.1 has essential genetic functions in hindbrain development and cranial neural crest cell differentiation. Development (2004) 1.12
Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy. BMC Public Health (2008) 1.11
The global state of influenza in children. Pediatr Infect Dis J (2008) 1.10
Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia. J Cereb Blood Flow Metab (2012) 1.08
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine (2005) 1.07
Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev Dyn (2013) 1.07
Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health (2012) 1.07
Vaccine for prevention of influenza in children. N Engl J Med (2014) 1.07
Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol Cell Biol (2008) 1.07
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine (2011) 1.06
Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One (2008) 1.06
Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. J Clin Virol (2010) 1.06
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity. Dev Biol (2007) 1.05
Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol Cell Proteomics (2009) 1.05
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis (2012) 1.05
Vaccinations in children with cancer. Vaccine (2010) 1.05
Impact of human bocavirus on children and their families. J Clin Microbiol (2008) 1.04
p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity. Mol Cell Biol (2007) 1.04
Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med (2005) 1.04
Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol (2010) 1.03
Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy. BMC Public Health (2010) 1.03
Induction of HoxB transcription by retinoic acid requires actin polymerization. Mol Biol Cell (2009) 1.03
Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr (2006) 1.03
Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling. Mol Pharm (2013) 1.03
Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J (2013) 1.03
Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Pediatr Infect Dis J (2012) 1.02
Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke. PLoS One (2013) 1.02
Update of the 2009 Italian Pediatric Society Guidelines about management of fever in children. Clin Ther (2012) 1.02